Retina diabetic Macular oedema
نویسندگان
چکیده
© Touch MEdical MEdia 2013 45 Abstract diabetic macular oedema (dMo) is a leading cause of vision loss in the working-age population worldwide. Numerous early studies suggest an important role for intravitreal anti-VEGF agents such as bevacizumab in the management of dMo. We reviewed manuscripts that had investigated pharmacokinetic, efficacy, safety, dose and frequency of intravitreal bevacizumab (iVB) injections as well as effect of macular ischaemia, initial macular thickness and optical coherence tomography (ocT) patterns of dMo on the final results of treatment with iVB. in summery literature searches disclosed that almost all studies published up to now provided evidence supporting use of iVB for treatment of either naïve or persistent dMo in short and long term up to 2 years.
منابع مشابه
Retinal vessel dilatation and elongation precedes diabetic macular oedema.
AIMS/BACKGROUND Retinal vessel dilatation is a well known phenomenon in diabetes. In this study, the theory of whether excessive changes in diameter and length of retinal vessels occur in the development of diabetic macular oedema was tested, supporting a hypothesis that the development of diabetic macular oedema may be linked to hydrostatic pressure changes described in Starling's law. METHO...
متن کاملMacular oedema: the role of soluble mediators.
Extracellular accumulation of fluid resulting in oedema is well tolerated in most tissues of the body, but in the retina, it results in dysfunction of retinal neurons. Collection of fluid in the macula is called macular oedema and when the fovea is involved, it results in decreased visual acuity. Macular oedema occurs in a wide variety of ocular diseases and is one of the most prevalent causes ...
متن کاملPosterior Segment Diabetic Macular Oedema
Diabetic macular oedema (DMO) is a leading cause of vision loss in the working-age population worldwide. Corticosteroid drugs have been demonstrated to inhibit the expression of both the vascular endothelial growth factor (VEGF) gene and other anti-inflammatory mediators, such as prostaglandins. Triamcinolone, fluocinolone and dexamethasone are the main steroids that have been studied for the t...
متن کاملDiode laser photocoagulation for diabetic macular oedema.
AIMS This study aimed to investigate whether diode laser irradiation, which is poorly absorbed by haemoglobin, can induce closure of leaking retinal microvascular lesions in the treatment of diabetic macular oedema. METHODS Thirty three eyes with clinically significant diabetic macular oedema were treated with a diode laser. Fundus evaluation before and after treatment included visual acuity,...
متن کاملIntravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study
BACKGROUND Diabetic macular oedema is the leading causes of blindness. Laser photocoagulation reduces the risk of visual loss. However recurrences are common and despite laser treatment, patients with diabetic macular oedema experienced progressive loss of vision. Stabilization of the blood retinal barrier introduces a rationale for intravitreal triamcinolone treatment in diabetic macular oedem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013